Novo Nordisk’s new Wegovy pill just set a wild record—prescriptions shot up nearly 500% in week two, totally crushing every other GLP-1 launch (even Eli Lilly’s Zepbound). And get this: the real numbers are probably way higher because they don’t even count direct-to-consumer or telehealth sales. Pills are about to make weight-loss meds mainstream, and Novo just sprinted ahead of the competition. Pharma drama, anyone? #Health #BodyHealth #Wegovy